Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study.

Men with prostate cancer treated with androgen deprivation therapy had a higher likelihood of developing new comorbidities than men who did not receive androgen deprivation therapy. Our results support the need for developing coordinated care models that effectively address multiple chronic diseases experienced by prostate cancer survivors.